Scholars Central

Conference abstractPublished 7 Oct 2022

mRNA vaccines: Mode of delivery and therapeutic potential

Authors: Nadeem Kizilbash

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

mRNA vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. For SARSCoV- 2 virus, the vaccine delivers molecules of mRNA that code for the Viral Spike Protein to Antigen Presenting Cells (APC). These protein molecules create an adaptive immune response that teaches the body to identify and destroy the attacking pathogen. The mRNA vaccine is delivered as a co-formulation in lipid nanoparticles that protect the mRNA strands and help their absorption into the cells. For the mRNA vaccine to be successful, sufficient mRNA must enter the host cell cytoplasm to stimulate production of specific antigens. But mRNA molecules are too large to cross the cell membrane by simple diffusion and they are also negatively charged like the cell membrane, which causes mutual electrostatic repulsion. However, Dendritic cells can readily absorb the mRNA molecules via Phagocytosis. Recent Publications: 1. Ambreen, J., Khachfe, H.M. & Kizilbash, N. “A Review of Synthetic Approaches and Biological Activity of Substituted Hydrazones” Anal. Chem. Ind. J. 21(5):170-175, 2021.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Immune Disorders & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Immune Disorders & Therapy
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Nadeem Kizilbash”